Stemtech

Stemtech PEG

PEG Ratio (Price/Earnings-to-Growth) of Stemtech (STEK) as of Oct 19, 2026.

PEG

-0.00

YoY

88.98%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Stemtech is 2024 -0.00 . PEG Ratio (Price/Earnings-to-Growth) of Stemtech was 2023 -0.00 . It decreases by 88.98% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stemtech Stock analysis

What does Stemtech do? Stemtech Corp, headquartered in Naples, Florida, develops nutritional supplements focused on supporting stem cell function. The company, listed on 15 September 2014, employs 45 full-time staff and operates internationally through subsidiaries and independent distributors. Its products, marketed under brands like RCM System, Stemflo MigraStem, and Cellect One Rapid Renew, enhance stem cell activity for health renewal. Segments include North America, Latin America, and Asia. Stemtech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stemtech stock

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Stemtech since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Stemtech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Stemtech

All Key Metrics — Stemtech